Clinic News

Latest in Cardiology

ACC, AHA Release New Clinical Guideline For Managing Dyslipidemia
The new ACC/AHA Guideline on the Management of Dyslipidemia offers a comprehensive â€œone-stop shopâ€ for addressing the evaluation, management and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a) (Lp[a]).
DANCAVAS: Severe Aortic, Iliac Calcification Associated With Higher Risk of Aortic Events, MALEs
Severe aortic and iliac calcification was associated with a significantly higher risk of major adverse limb events (MALEs) and aortic events, according to a prospective cohort study from the DANCAVAS trials published March 2 in Circulation. These results suggest that quantifying aortic calcification may provide valuable prognostic information and improve the risk stratification in patients […]
JACC State-of-the-Art Review Highlights Growing Need For dLVAD-Related Emergency Response Resources
With the population of stage D heart failure (HF) patients supported with durable left ventricular assist devices (dLVAD) rapidly expanding, a State-of-the-Art Review published in JACC provides a comprehensive overview of support and management of dLVAD-related emergencies, with an intent to provide a rapid-response guide for clinicians who encounter emergencies in patients with dLVADs.
4 Ways ACC State Chapters Are Advancing Access to Care, Strengthening the CV Workforce
ACC State Chapters across the country have been hard at work in recent weeks advancing policies that expand access to life-saving cardiovascular care and support the health care workforce.
AI-Enabled Clinician: Heart Failure Prediction Using AI-Enabled ECG
In this episode, ACC Chief Innovation Officer Dr. Ami Bhatt and Dr. Akshay Desai analyze how AI-enabled electrocardiogram (ECG) can improve the prediction of heart failure.
Management of Checkpoint Inhibitor Myocarditis in the CCU
A 75-year-old man with a history of remote anterior ST-segment elevation myocardial infarction and stage IV malignant melanoma treated with combination immunotherapy (ipilimumab/nivolumab) presented to the oncology clinic with 3 days of exertional dyspnea and 24 hours of diplopia and neck weakness.
State of the States 2025: ACC Chapters Advancing CV Care Through Education, Advocacy, and Connection
In 2025, ACC Chapters across the U.S. demonstrated the power of grassroots leadership in advancing cardiovascular care. Through record-breaking educational meetings, landmark advocacy victories, innovative equity initiatives, and expanded professional development...
Eagleâ€™s Eye View: Beta-Blocker vs. Calcium-Channel Blocker in HCM
In this weekâ€™s View, Dr. Eagleâ€¯looks at the differential effect of bisoprolol versus verapamil in nonobstructive hypertrophic cardiomyopathy (HCM) treatment.
JACC: Asia State-of-the-Art Review Spotlights Role of AI in CV Medicine
With technological advances like artificial intelligence (AI), machine learning and digital health tools moving from concept into clinical practice, a State-of-the-Art Review in JACC: Asia offers a comprehensive look at digital innovation spanning the full spectrum of cardiology from prevention to treatment to research.
JACC Spotlight Issue Focuses on CV Statistics in US
A special JACC spotlight issue supporting the journalâ€™s recent Cardiovascular Statistics 2026 (JACC Stats) report published online earlier this year offers a comprehensive snapshot of cardiovascular health in the U.S. today. The focused issue, which also includes the inaugural report, expands the analysis beyond clinical disease to the broader drivers of cardiovascular health, examining trends […]